Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?

Código QR

Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?

Guardado en:

Detalles Bibliográficos
Autor principal:	Marc Lipsitch
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2014
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/f2bacd0cb23f4fb6a1f7197e5ad19b42
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Reply to “Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?”
por: Arturo Casadevall, et al.
Publicado: (2014)

Rethinking Biosafety in Research on Potential Pandemic Pathogens
por: Marc Lipsitch, et al.
Publicado: (2012)

Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens
por: Marc Lipsitch, et al.
Publicado: (2014)

Erratum for Lipsitch and Inglesby, Moratorium on Research Intended To Create Novel Potential Pandemic Pathogens
por: Marc Lipsitch, et al.
Publicado: (2015)

An Epistemological Perspective on the Value of Gain-of-Function Experiments Involving Pathogens with Pandemic Potential
por: Arturo Casadevall, et al.
Publicado: (2014)

Assessing and Managing the Risks of Potential Pandemic Pathogen Research
por: Daniel J. Rozell
Publicado: (2015)

Proposed Changes to U.S. Policy on Potential Pandemic Pathogen Oversight and Implementation
por: Thomas V. Inglesby, et al.
Publicado: (2020)

Risks and Benefits of Gain-of-Function Experiments with Pathogens of Pandemic Potential, Such as Influenza Virus: a Call for a Science-Based Discussion
por: Arturo Casadevall, et al.
Publicado: (2014)

Danger of Potential-Pandemic-Pathogen Research Enterprises
por: Lynn C. Klotz
Publicado: (2015)

Vagueness and Costs of the Pause on Gain-of-Function (GOF) Experiments on Pathogens with Pandemic Potential, Including Influenza Virus
por: Michael J. Imperiale, et al.
Publicado: (2014)

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?
por: Marc Lipsitch, et al.
Publicado: (2016)

Is the Debate and “Pause” on Experiments That Alter Pathogens with Pandemic Potential Influencing Future Plans of Graduate Students and Postdoctoral Fellows?
por: Julie K. Pfeiffer
Publicado: (2015)

<italic toggle="yes">mBio</italic> Addresses the Pause in Gain-of-Function (GOF) Experiments Involving Pathogens with Pandemic Potential (PPP)
por: Arturo Casadevall, et al.
Publicado: (2014)

Reply to “Studies on Influenza Virus Transmission between Ferrets: the Public Health Risks Revisited”
por: Marc Lipsitch, et al.
Publicado: (2015)

Does Pandemic A/H1N1 Virus Have the Potential To Become More Pathogenic?
por: Natalia A. Ilyushina, et al.
Publicado: (2010)

Ethical alternatives to experiments with novel potential pandemic pathogens.
por: Marc Lipsitch, et al.
Publicado: (2014)

Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments
por: Nicholas Greig Evans
Publicado: (2014)

Reply to “Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments”
por: Arturo Casadevall, et al.
Publicado: (2014)

The Pathogenic Potential of a Microbe
por: Arturo Casadevall
Publicado: (2017)

Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness
por: S. Schultz-Cherry, et al.
Publicado: (2014)

A Single Human Cerebral Malaria Histopathologic Study Can Be Worth a Thousand Experiments
por: David J. Sullivan
Publicado: (2015)

Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks
por: Sriharshita Musunuri, et al.
Publicado: (2021)

Field Science—the Nature and Utility of Scientific Fields
por: Arturo Casadevall, et al.
Publicado: (2015)

Use of Highly Pathogenic Avian Influenza A(H5N1) Gain-Of-Function Studies for Molecular-Based Surveillance and Pandemic Preparedness
por: C. Todd Davis, et al.
Publicado: (2014)

H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity
por: David M. Morens, et al.
Publicado: (2013)

Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic
por: Michael J. Imperiale, et al.
Publicado: (2020)

Oral Epithelial Cells Distinguish between <i>Candida</i> Species with High or Low Pathogenic Potential through MicroRNA Regulation
por: Márton Horváth, et al.
Publicado: (2021)

Comparative Genomics of Recent Shiga Toxin-Producing <named-content content-type="genus-species">Escherichia coli</named-content> O104:H4: Short-Term Evolution of an Emerging Pathogen
por: Yonatan H. Grad, et al.
Publicado: (2013)

Pandemics and People
por: Michael J. Imperiale
Publicado: (2020)

Males Are Overrepresented among Life Science Researchers Committing Scientific Misconduct
por: Ferric C. Fang, et al.
Publicado: (2013)

Bacteriophages as Pathogens and Immune Modulators?
por: A. Lengeling, et al.
Publicado: (2013)

Erratum for Schloss et al., “Support Science by Publishing in Scientific Society Journals”
por: Patrick D. Schloss, et al.
Publicado: (2017)

Are Men More Likely than Women To Commit Scientific Misconduct? Maybe, Maybe Not
por: Anna Kaatz, et al.
Publicado: (2013)

Ancient-Pathogen Genomics: Coming of Age?
por: Adrian M. Whatmore
Publicado: (2014)

The Presence of Female Conveners Correlates with a Higher Proportion of Female Speakers at Scientific Symposia
por: Arturo Casadevall, et al.
Publicado: (2014)

Interspecies Communication among Commensal and Pathogenic Streptococci
por: Laura C. Cook, et al.
Publicado: (2013)

Polymicrobial Interactions Operative during Pathogen Transmission
por: Hannah M. Rowe, et al.
Publicado: (2021)

Oxygen Limitation within a Bacterial Aggregate
por: Aimee K. Wessel, et al.
Publicado: (2014)

Bacteriophages Limit the Existence Conditions for Conjugative Plasmids
por: Ellie Harrison, et al.
Publicado: (2015)

Completion of an Experiment
por: Michael J. Imperiale, et al.
Publicado: (2018)